StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Thanks for the 150,000 $0.05 warrants!!!

<< Previous

Bullboard Posts

Next >>

Comment by Saaweeeetdreamson Apr 07, 2021 4:20pm

111 Views

Post# 32951234

RE:Thanks for the 150,000 $0.05 warrants!!!

The fundamentals haven't changed? The entire business model has changed. The goal posts have been moved, no the entire game changed. Let me dumb it down for you, think of Aristotle as an octopus with 8 arms and those arms are partners selling Aristotle, now with the LOI the octopus has only one arm and we sell it alone. The market has spoken down 50% in a week.

simple enough for you?

<< Previous

Bullboard Posts

Next >>

Online behaviour puts Canadians at risk of cyberattacks, study finds